Cargando…

Modelling the impact of effective private provider engagement on tuberculosis control in urban India

In India, the country with the world’s largest burden of tuberculosis (TB), most patients first seek care in the private healthcare sector, which is fragmented and unregulated. Ongoing initiatives are demonstrating effective approaches for engaging with this sector, and form a central part of India’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arinaminpathy, Nimalan, Deo, Sarang, Singh, Simrita, Khaparde, Sunil, Rao, Raghuram, Vadera, Bhavin, Kulshrestha, Niraj, Gupta, Devesh, Rade, Kiran, Nair, Sreenivas Achuthan, Dewan, Puneet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405912/ https://www.ncbi.nlm.nih.gov/pubmed/30846709 http://dx.doi.org/10.1038/s41598-019-39799-7

Ejemplares similares

Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
por: Arinaminpathy, Nimalan, et al.
Publicado: (2021)

Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019)

Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
por: Deo, Sarang, et al.
Publicado: (2020)

What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India
por: Deo, Sarang, et al.
Publicado: (2019)

The number of privately treated tuberculosis cases in India: an estimation from drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2016)

The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2020)

Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement
por: Parmar, Malik M., et al.
Publicado: (2018)

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
por: Nair, Sreenivas Achuthan, et al.
Publicado: (2016)

The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
por: Mandal, Sandip, et al.
Publicado: (2021)

The potential impact of vaccination on tuberculosis burden in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
por: Dave, Paresh, et al.
Publicado: (2015)

“Before Xpert I only had my expertise”: A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities
por: McDowell, Andrew, et al.
Publicado: (2018)

Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers: evidence from India
por: Deo, Sarang, et al.
Publicado: (2020)

HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from India
por: Kumar, Ajay MV, et al.
Publicado: (2016)

Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India
por: Raizada, Neeraj, et al.
Publicado: (2014)

Can Follow-Up Examination of Tuberculosis Patients Be Simplified? A Study in Chhattisgarh, India
por: Kundu, Debashish, et al.
Publicado: (2012)

Evaluation of TB Case Finding through Systematic Contact Investigation, Chhattisgarh, India
por: Khaparde, Kshitij, et al.
Publicado: (2015)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
por: Khaparde, Sunil, et al.
Publicado: (2017)

Community health worker-led, technology-enabled private sector intervention for diabetes and hypertension management among urban poor: a retrospective cohort study from large Indian metropolitan city
por: Deo, Sarang, et al.
Publicado: (2021)

Tuberculosis Management Practices by Private Practitioners in Andhra Pradesh, India
por: Achanta, Shanta, et al.
Publicado: (2013)

Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2010)

Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India
por: Deo, Sarang, et al.
Publicado: (2021)

Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India
por: Raizada, Neeraj, et al.
Publicado: (2018)

Quality of active case-finding for tuberculosis in India: a national level secondary data analysis
por: Shewade, Hemant Deepak, et al.
Publicado: (2023)

The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
por: Raizada, Neeraj, et al.
Publicado: (2015)

Source of Previous Treatment for Re-Treatment TB Cases Registered under the National TB Control Programme, India, 2010
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2011)

Sputum Smear Microscopy at Two Months into Continuation-Phase: Should It Be Done in All Patients with Sputum Smear-Positive Tuberculosis?
por: Gandhi, Mohit Padamchand, et al.
Publicado: (2012)

The effects of a partitioned var gene repertoire of Plasmodium falciparum on antigenic diversity and the acquisition of clinical immunity
por: Recker, Mario, et al.
Publicado: (2008)

Effective use of a Limited Antiviral Stockpile for Pandemic Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2009)

High Diabetes Prevalence among Tuberculosis Cases in Kerala, India
por: Balakrishnan, Shibu, et al.
Publicado: (2012)

Comparing Same Day Sputum Microscopy with Conventional Sputum Microscopy for the Diagnosis of Tuberculosis – Chhattisgarh, India
por: Nayak, Priyakanta, et al.
Publicado: (2013)

Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review
por: Braham, Christy A., et al.
Publicado: (2018)

Viral Dynamics and Mathematical Models
por: Arinaminpathy, Nimalan, et al.
Publicado: (2014)

Responsible travel to and within India during the COVID-19 pandemic
por: Mandal, Sandip, et al.
Publicado: (2021)

Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis
por: Mandal, Sandip, et al.
Publicado: (2021)

India’s pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis
por: Mandal, Sandip, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f7ggo2k7jcphvlskdurkgcad1h